García-Cabezas S, Rivin del Campo E, Solivera-Vela J, Palacios-Eito A. Re-irradiation for high-grade gliomas: Has anything changed? World J Clin Oncol 2021; 12(9): 767-786 [PMID: 34631441 DOI: 10.5306/wjco.v12.i9.767]
Corresponding Author of This Article
Amalia Palacios-Eito, MD, PhD, Associate Professor, Chief Doctor, Department of Radiation Oncology, Reina Sofia University Hospital, Avda. Menéndez Pidal, s/n, Cordoba 14004, Spain. amalia.palacios.sspa@juntadeandalucia.es
Research Domain of This Article
Oncology
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 5 Scoring scheme and new prognostic groups of the “New Combs Score”
Prognostic factors
Prognostic value
Primary histology
Glioblastoma, WHO IV
2
Anaplastic glioma, WHO III
1
Low-grade glioma, WHO I/II
0
Age
≥ 50 yr
1
< 50 yr
0
Time between primary RT and re-RT
≤ 12 meses
1
> 12 meses
0
Re-resection performed
No
1
Yes
0
KPS
< 80%
1
≥ 80%
0
Tumor volume (PTV)
> 47 mL
1
≤ 47 mL
0
Scoring group
Scoring value/mOS
a
0–1/19.5 mo
b
2–3/11.3 mo
c
4–5/8.1 mo
d
6–7/5.5 mo
Citation: García-Cabezas S, Rivin del Campo E, Solivera-Vela J, Palacios-Eito A. Re-irradiation for high-grade gliomas: Has anything changed? World J Clin Oncol 2021; 12(9): 767-786